Methods for identifying beta-glucan binding to immune cells

This disclosure describes, in one aspect, a method for identifying β-glucan binding to immune cells of a subject. Generally, the method includes obtaining a blood sample from the subject, the blood sample comprising immune cells, adding soluble β-glucan to at least a portion of the blood sample and...

Full description

Saved in:
Bibliographic Details
Main Authors Michel, Kyle S, Grossman, William J, Bose, Nandita, Danielson, Michael E, Nelson, Mariana I, Antonysamy, Mary A, Walsh, Richard M
Format Patent
LanguageEnglish
Published 25.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This disclosure describes, in one aspect, a method for identifying β-glucan binding to immune cells of a subject. Generally, the method includes obtaining a blood sample from the subject, the blood sample comprising immune cells, adding soluble β-glucan to at least a portion of the blood sample and incubating the mixture under conditions allowing the soluble β-glucan to bind to the immune cells, and detecting soluble β-glucan bound to the immune cells. In another aspect, this disclosure describes a method that generally includes identifying the subject as a low binder of β-glucan, and co-administering to the subject a soluble β-glucan and an antibody preparation capable of converting the subject from a low binder to a high binder.
Bibliography:Application Number: US201314398019